My father once remarked that “of all the forms of inequality, injustice in health care is the most shocking and inhumane.” These words continue to resonate with one of the largest public health challenges today: obesity. In America, millions of families face obesity, a chronic disease that affects low-income and minority communities disproportionately. Yet, many are denied treatments that experts deem both effective and transformative.
This is not merely a health care issue, but one of fairness and equal opportunity. States like California have made decisions to limit coverage for GLP-1 treatments for obesity. This highlights a national issue where effective care is accessible, but mostly to those who can afford it.
There is a longstanding belief that a person’s place of residence or income should not dictate their ability to lead a healthy life. However, effective obesity treatment often remains available only to those with private insurance or financial means. This creates a system where access to care is overly dependent on income.
Obesity is linked to numerous chronic illnesses, including heart disease, stroke, diabetes, kidney disease, and hypertension. These conditions shorten lifespans, strain families, and increase health care costs. Recent obesity treatment advancements have given many hope. These treatments help manage this chronic disease and focus on health rather than appearance.
Parents find renewed energy to engage with their children. Workers improve their health, enhancing their ability to support their families. Patients previously struggling with ineffective treatments are witnessing progress.
However, this hope is futile if only the affluent can access it. When Medicaid does not cover obesity treatment, low-income patients often wait until their condition worsens. Delaying care does not cut expenses; it shifts them to emergency rooms, hospitals, and often results in preventable suffering.
Policymakers should acknowledge obesity treatment as essential health care, rather than a luxury. This is crucial in communities facing higher obesity and chronic disease rates. Health disparities cannot reduce while denying access to promising treatment options.
The stigma around obesity heavily influences public discourse. Individuals combating obesity frequently face judgment instead of compassion. This condition is moralized rather than treated with due seriousness, unlike other chronic diseases.
We would never suggest that a cancer patient simply strive harder. Likewise, obesity deserves respect, seriousness, and adequate treatment access, like any chronic disease.
Health care should not be contingent on ZIP codes, insurance types, or income. Medicaid exists to ensure care does not equate with wealth. Excluding obesity treatment defies that mission.
Policymakers need to resolve who deserves access to modern medicine. A healthier nation cannot form while neglecting communities burdened by severe health inequities. Broadening obesity treatment access through Medicaid will not resolve every health care challenge but signifies a critical step toward making modern medicine accessible to all Americans, especially those in need.
Ultimately, a society is measured not by the fortunate accessing lifesaving treatment, but by the willingness to extend care to the most needed.
Martin Luther King III is a global humanitarian and activist, and the eldest son of Rev. Martin Luther King Jr. The views expressed here are the author’s own.